ARC in Hemorrhagic Stroke

NCT02386202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2015-12-02

No results posted yet for this study

Summary

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Conditions

  • Hemorrhagic Stroke
  • Augmented Renal Clearance

Interventions

OTHER

No intervention

No interventions

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Kathryn A Morbitzer, PharmD · UNC Eshelman School of Pharmacy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02386202 on ClinicalTrials.gov